Table of Content

1 Market Overview of Neuroblastoma Treatment
1.1 Neuroblastoma Treatment Market Overview
1.1.1 Neuroblastoma Treatment Product Scope
1.1.2 Neuroblastoma Treatment Market Status and Outlook
1.2 Global Neuroblastoma Treatment Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Neuroblastoma Treatment Market Size by Region (2018-2029)
1.4 Global Neuroblastoma Treatment Historic Market Size by Region (2018-2024)
1.5 Global Neuroblastoma Treatment Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Neuroblastoma Treatment Market Size (2018-2029)
1.6.1 North America Neuroblastoma Treatment Market Size (2018-2029)
1.6.2 Europe Neuroblastoma Treatment Market Size (2018-2029)
1.6.3 Asia-Pacific Neuroblastoma Treatment Market Size (2018-2029)
1.6.4 Latin America Neuroblastoma Treatment Market Size (2018-2029)
1.6.5 Middle East & Africa Neuroblastoma Treatment Market Size (2018-2029)
2 Neuroblastoma Treatment Market by Type
2.1 Introduction
2.1.1 Combination Chemotherapy
2.1.2 Monoclonal Antibody Therapy
2.1.3 Vaccine Therapy
2.1.4 Chimeric Antigen Receptor T-Cell Immunotherapy
2.1.5 Oncolytic Virus Therapy
2.2 Global Neuroblastoma Treatment Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Neuroblastoma Treatment Historic Market Size by Type (2018-2024)
2.2.2 Global Neuroblastoma Treatment Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Neuroblastoma Treatment Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Neuroblastoma Treatment Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Neuroblastoma Treatment Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Neuroblastoma Treatment Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Neuroblastoma Treatment Revenue Breakdown by Type (2018-2029)
3 Neuroblastoma Treatment Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Others
3.2 Global Neuroblastoma Treatment Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Neuroblastoma Treatment Historic Market Size by Application (2018-2024)
3.2.2 Global Neuroblastoma Treatment Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Neuroblastoma Treatment Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Neuroblastoma Treatment Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Neuroblastoma Treatment Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Neuroblastoma Treatment Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Neuroblastoma Treatment Revenue Breakdown by Application (2018-2029)
4 Neuroblastoma Treatment Competition Analysis by Players
4.1 Global Neuroblastoma Treatment Market Size by Players (2018-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Neuroblastoma Treatment as of 2022)
4.3 Date of Key Players Enter into Neuroblastoma Treatment Market
4.4 Global Top Players Neuroblastoma Treatment Headquarters and Area Served
4.5 Key Players Neuroblastoma Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Neuroblastoma Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Seattle Children’s
5.1.1 Seattle Children’s Profile
5.1.2 Seattle Children’s Main Business
5.1.3 Seattle Children’s Neuroblastoma Treatment Products, Services and Solutions
5.1.4 Seattle Children’s Neuroblastoma Treatment Revenue (US$ Million) & (2018-2024)
5.1.5 Seattle Children’s Recent Developments
5.2 CureSearch
5.2.1 CureSearch Profile
5.2.2 CureSearch Main Business
5.2.3 CureSearch Neuroblastoma Treatment Products, Services and Solutions
5.2.4 CureSearch Neuroblastoma Treatment Revenue (US$ Million) & (2018-2024)
5.2.5 CureSearch Recent Developments
5.3 Texas Children’s
5.3.1 Texas Children’s Profile
5.3.2 Texas Children’s Main Business
5.3.3 Texas Children’s Neuroblastoma Treatment Products, Services and Solutions
5.3.4 Texas Children’s Neuroblastoma Treatment Revenue (US$ Million) & (2018-2024)
5.3.5 NANT Recent Developments
5.4 NANT
5.4.1 NANT Profile
5.4.2 NANT Main Business
5.4.3 NANT Neuroblastoma Treatment Products, Services and Solutions
5.4.4 NANT Neuroblastoma Treatment Revenue (US$ Million) & (2018-2024)
5.4.5 NANT Recent Developments
5.5 Sino Biopharmaceutical
5.5.1 Sino Biopharmaceutical Profile
5.5.2 Sino Biopharmaceutical Main Business
5.5.3 Sino Biopharmaceutical Neuroblastoma Treatment Products, Services and Solutions
5.5.4 Sino Biopharmaceutical Neuroblastoma Treatment Revenue (US$ Million) & (2018-2024)
5.5.5 Sino Biopharmaceutical Recent Developments
5.6 Jiangsu Hengrui Medicine Co.,Ltd.
5.6.1 Jiangsu Hengrui Medicine Co.,Ltd. Profile
5.6.2 Jiangsu Hengrui Medicine Co.,Ltd. Main Business
5.6.3 Jiangsu Hengrui Medicine Co.,Ltd. Neuroblastoma Treatment Products, Services and Solutions
5.6.4 Jiangsu Hengrui Medicine Co.,Ltd. Neuroblastoma Treatment Revenue (US$ Million) & (2018-2024)
5.6.5 Jiangsu Hengrui Medicine Co.,Ltd. Recent Developments
5.7 Fosun Pharmaceutical
5.7.1 Fosun Pharmaceutical Profile
5.7.2 Fosun Pharmaceutical Main Business
5.7.3 Fosun Pharmaceutical Neuroblastoma Treatment Products, Services and Solutions
5.7.4 Fosun Pharmaceutical Neuroblastoma Treatment Revenue (US$ Million) & (2018-2024)
5.7.5 Fosun Pharmaceutical Recent Developments
5.8 Novartis
5.8.1 Novartis Profile
5.8.2 Novartis Main Business
5.8.3 Novartis Neuroblastoma Treatment Products, Services and Solutions
5.8.4 Novartis Neuroblastoma Treatment Revenue (US$ Million) & (2018-2024)
5.8.5 Novartis Recent Developments
5.9 Juno Therapeutics
5.9.1 Juno Therapeutics Profile
5.9.2 Juno Therapeutics Main Business
5.9.3 Juno Therapeutics Neuroblastoma Treatment Products, Services and Solutions
5.9.4 Juno Therapeutics Neuroblastoma Treatment Revenue (US$ Million) & (2018-2024)
5.9.5 Juno Therapeutics Recent Developments
5.10 Kite Pharma
5.10.1 Kite Pharma Profile
5.10.2 Kite Pharma Main Business
5.10.3 Kite Pharma Neuroblastoma Treatment Products, Services and Solutions
5.10.4 Kite Pharma Neuroblastoma Treatment Revenue (US$ Million) & (2018-2024)
5.10.5 Kite Pharma Recent Developments
5.11 Adaptimmune
5.11.1 Adaptimmune Profile
5.11.2 Adaptimmune Main Business
5.11.3 Adaptimmune Neuroblastoma Treatment Products, Services and Solutions
5.11.4 Adaptimmune Neuroblastoma Treatment Revenue (US$ Million) & (2018-2024)
5.11.5 Adaptimmune Recent Developments
6 North America
6.1 North America Neuroblastoma Treatment Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Neuroblastoma Treatment Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Neuroblastoma Treatment Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Neuroblastoma Treatment Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Neuroblastoma Treatment Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Neuroblastoma Treatment Market Dynamics
11.1 Neuroblastoma Treatment Industry Trends
11.2 Neuroblastoma Treatment Market Drivers
11.3 Neuroblastoma Treatment Market Challenges
11.4 Neuroblastoma Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Neuroblastoma Treatment Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
Table 2. Global Neuroblastoma Treatment Market Size by Region (2018-2024) & (US$ Million)
Table 3. Global Neuroblastoma Treatment Market Size Share by Region (2018-2024)
Table 4. Global Neuroblastoma Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 5. Global Neuroblastoma Treatment Forecasted Market Size Share by Region (2024-2029)
Table 6. Global Neuroblastoma Treatment Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
Table 7. Global Neuroblastoma Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 8. Global Neuroblastoma Treatment Revenue Market Share by Type (2018-2024)
Table 9. Global Neuroblastoma Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 10. Global Neuroblastoma Treatment Revenue Market Share by Type (2024-2029)
Table 11. North America Neuroblastoma Treatment Revenue by Type (2018-2024) & (US$ Million)
Table 12. North America Neuroblastoma Treatment Revenue by Type (2024-2029) & (US$ Million)
Table 13. Europe Neuroblastoma Treatment Revenue by Type (2018-2024) & (US$ Million)
Table 14. Europe Neuroblastoma Treatment Revenue by Type (2024-2029) & (US$ Million)
Table 15. Asia-Pacific Neuroblastoma Treatment Revenue by Type (2018-2024) & (US$ Million)
Table 16. Asia-Pacific Neuroblastoma Treatment Revenue by Type (2024-2029) & (US$ Million)
Table 17. Latin America Neuroblastoma Treatment Revenue by Type (2018-2024) & (US$ Million)
Table 18. Latin America Neuroblastoma Treatment Revenue by Type (2024-2029) & (US$ Million)
Table 19. Middle East and Africa Neuroblastoma Treatment Revenue by Type (2018-2024) & (US$ Million)
Table 20. Middle East and Africa Neuroblastoma Treatment Revenue by Type (2024-2029) & (US$ Million)
Table 21. Global Neuroblastoma Treatment Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
Table 22. Global Neuroblastoma Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 23. Global Neuroblastoma Treatment Revenue Market Share by Application (2018-2024)
Table 24. Global Neuroblastoma Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 25. Global Neuroblastoma Treatment Revenue Market Share by Application (2024-2029)
Table 26. North America Neuroblastoma Treatment Revenue by Application (2018-2024) & (US$ Million)
Table 27. North America Neuroblastoma Treatment Revenue by Application (2024-2029) & (US$ Million)
Table 28. Europe Neuroblastoma Treatment Revenue by Application (2018-2024) & (US$ Million)
Table 29. Europe Neuroblastoma Treatment Revenue by Application (2024-2029) & (US$ Million)
Table 30. Asia-Pacific Neuroblastoma Treatment Revenue by Application (2018-2024) & (US$ Million)
Table 31. Asia-Pacific Neuroblastoma Treatment Revenue by Application (2024-2029) & (US$ Million)
Table 32. Latin America Neuroblastoma Treatment Revenue by Application (2018-2024) & (US$ Million)
Table 33. Latin America Neuroblastoma Treatment Revenue by Application (2024-2029) & (US$ Million)
Table 34. Middle East and Africa Neuroblastoma Treatment Revenue by Application (2018-2024) & (US$ Million)
Table 35. Middle East and Africa Neuroblastoma Treatment Revenue by Application (2024-2029) & (US$ Million)
Table 36. Global Neuroblastoma Treatment Revenue (US$ Million) by Players (2018-2024)
Table 37. Global Neuroblastoma Treatment Revenue Market Share by Players (2018-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Neuroblastoma Treatment as of 2022)
Table 39. Date of Key Players Enter into Neuroblastoma Treatment Market
Table 40. Global Neuroblastoma Treatment Key Players Headquarters and Area Served
Table 41. Neuroblastoma Treatment Product Solution and Service
Table 42. Global Neuroblastoma Treatment Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Seattle Children’s Basic Information List
Table 45. Seattle Children’s Description and Business Overview
Table 46. Seattle Children’s Neuroblastoma Treatment Products, Services and Solutions
Table 47. Revenue (US$ Million) in Neuroblastoma Treatment Business of Seattle Children’s (2018-2024)
Table 48. Seattle Children’s Recent Developments
Table 49. CureSearch Basic Information List
Table 50. CureSearch Description and Business Overview
Table 51. CureSearch Neuroblastoma Treatment Products, Services and Solutions
Table 52. Revenue (US$ Million) in Neuroblastoma Treatment Business of CureSearch (2018-2024)
Table 53. CureSearch Recent Developments
Table 54. Texas Children’s Basic Information List
Table 55. Texas Children’s Description and Business Overview
Table 56. Texas Children’s Neuroblastoma Treatment Products, Services and Solutions
Table 57. Revenue (US$ Million) in Neuroblastoma Treatment Business of Texas Children’s (2018-2024)
Table 58. Texas Children’s Recent Developments
Table 59. NANT Basic Information List
Table 60. NANT Description and Business Overview
Table 61. NANT Neuroblastoma Treatment Products, Services and Solutions
Table 62. Revenue (US$ Million) in Neuroblastoma Treatment Business of NANT (2018-2024)
Table 63. NANT Recent Developments
Table 64. Sino Biopharmaceutical Basic Information List
Table 65. Sino Biopharmaceutical Description and Business Overview
Table 66. Sino Biopharmaceutical Neuroblastoma Treatment Products, Services and Solutions
Table 67. Revenue (US$ Million) in Neuroblastoma Treatment Business of Sino Biopharmaceutical (2018-2024)
Table 68. Sino Biopharmaceutical Recent Developments
Table 69. Jiangsu Hengrui Medicine Co.,Ltd. Basic Information List
Table 70. Jiangsu Hengrui Medicine Co.,Ltd. Description and Business Overview
Table 71. Jiangsu Hengrui Medicine Co.,Ltd. Neuroblastoma Treatment Products, Services and Solutions
Table 72. Revenue (US$ Million) in Neuroblastoma Treatment Business of Jiangsu Hengrui Medicine Co.,Ltd. (2018-2024)
Table 73. Jiangsu Hengrui Medicine Co.,Ltd. Recent Developments
Table 74. Fosun Pharmaceutical Basic Information List
Table 75. Fosun Pharmaceutical Description and Business Overview
Table 76. Fosun Pharmaceutical Neuroblastoma Treatment Products, Services and Solutions
Table 77. Revenue (US$ Million) in Neuroblastoma Treatment Business of Fosun Pharmaceutical (2018-2024)
Table 78. Fosun Pharmaceutical Recent Developments
Table 79. Novartis Basic Information List
Table 80. Novartis Description and Business Overview
Table 81. Novartis Neuroblastoma Treatment Products, Services and Solutions
Table 82. Revenue (US$ Million) in Neuroblastoma Treatment Business of Novartis (2018-2024)
Table 83. Novartis Recent Developments
Table 84. Juno Therapeutics Basic Information List
Table 85. Juno Therapeutics Description and Business Overview
Table 86. Juno Therapeutics Neuroblastoma Treatment Products, Services and Solutions
Table 87. Revenue (US$ Million) in Neuroblastoma Treatment Business of Juno Therapeutics (2018-2024)
Table 88. Juno Therapeutics Recent Developments
Table 89. Kite Pharma Basic Information List
Table 90. Kite Pharma Description and Business Overview
Table 91. Kite Pharma Neuroblastoma Treatment Products, Services and Solutions
Table 92. Revenue (US$ Million) in Neuroblastoma Treatment Business of Kite Pharma (2018-2024)
Table 93. Kite Pharma Recent Developments
Table 94. Adaptimmune Basic Information List
Table 95. Adaptimmune Description and Business Overview
Table 96. Adaptimmune Neuroblastoma Treatment Products, Services and Solutions
Table 97. Revenue (US$ Million) in Neuroblastoma Treatment Business of Adaptimmune (2018-2024)
Table 98. Adaptimmune Recent Developments
Table 99. North America Neuroblastoma Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 100. North America Neuroblastoma Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 101. Europe Neuroblastoma Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 102. Europe Neuroblastoma Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 103. Asia-Pacific Neuroblastoma Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 104. Asia-Pacific Neuroblastoma Treatment Market Size by Region (2018-2024) & (US$ Million)
Table 105. Asia-Pacific Neuroblastoma Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 106. Asia-Pacific Neuroblastoma Treatment Market Share by Region (2018-2024)
Table 107. Asia-Pacific Neuroblastoma Treatment Market Share by Region (2024-2029)
Table 108. Latin America Neuroblastoma Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 109. Latin America Neuroblastoma Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 110. Latin America Neuroblastoma Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 111. Middle East & Africa Neuroblastoma Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 112. Middle East & Africa Neuroblastoma Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 113. Middle East & Africa Neuroblastoma Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 114. Neuroblastoma Treatment Market Trends
Table 115. Neuroblastoma Treatment Market Drivers
Table 116. Neuroblastoma Treatment Market Challenges
Table 117. Neuroblastoma Treatment Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Neuroblastoma Treatment Market Size Year-over-Year 2018-2029 & (US$ Million)
Figure 2. Global Neuroblastoma Treatment Market Size (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global Neuroblastoma Treatment Market Share by Regions: 2022 VS 2029
Figure 4. Global Neuroblastoma Treatment Forecasted Market Size Share by Region (2024-2029)
Figure 5. North America Neuroblastoma Treatment Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 6. Europe Neuroblastoma Treatment Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 7. Asia-Pacific Neuroblastoma Treatment Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 8. Latin America Neuroblastoma Treatment Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 9. Middle East & Africa Neuroblastoma Treatment Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 10. Product Picture of Combination Chemotherapy
Figure 11. Global Combination Chemotherapy Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 12. Product Picture of Monoclonal Antibody Therapy
Figure 13. Global Monoclonal Antibody Therapy Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 14. Product Picture of Vaccine Therapy
Figure 15. Global Vaccine Therapy Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 16. Product Picture of Chimeric Antigen Receptor T-Cell Immunotherapy
Figure 17. Global Chimeric Antigen Receptor T-Cell Immunotherapy Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 18. Product Picture of Oncolytic Virus Therapy
Figure 19. Global Oncolytic Virus Therapy Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 20. Global Neuroblastoma Treatment Market Size Share by Type: 2022 & 2029
Figure 21. North America Neuroblastoma Treatment Revenue Market Share by Type (2018-2029)
Figure 22. Europe Neuroblastoma Treatment Revenue Market Share by Type (2018-2029)
Figure 23. Asia-Pacific Neuroblastoma Treatment Revenue Market Share by Type (2018-2029)
Figure 24. Latin America Neuroblastoma Treatment Revenue Market Share by Type (2018-2029)
Figure 25. Middle East and Africa Neuroblastoma Treatment Revenue Market Share by Type (2018-2029)
Figure 26. Hospitals Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 27. Clinics Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 28. Others Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 29. Global Neuroblastoma Treatment Market Size Share by Application: 2022 & 2029
Figure 30. North America Neuroblastoma Treatment Revenue Market Share by Application (2018-2029)
Figure 31. Europe Neuroblastoma Treatment Revenue Market Share by Application (2018-2029)
Figure 32. Asia-Pacific Neuroblastoma Treatment Revenue Market Share by Application (2018-2029)
Figure 33. Latin America Neuroblastoma Treatment Revenue Market Share by Application (2018-2029)
Figure 34. Middle East and Africa Neuroblastoma Treatment Revenue Market Share by Application (2018-2029)
Figure 35. Neuroblastoma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 36. Global Top 5 and Top 10 Players Neuroblastoma Treatment Market Share in 2022
Figure 37. North America Neuroblastoma Treatment Market Share by Country (2018-2029)
Figure 38. United States Neuroblastoma Treatment Market Size (2018-2029) & (US$ Million)
Figure 39. Canada Neuroblastoma Treatment Market Size (2018-2029) & (US$ Million)
Figure 40. Germany Neuroblastoma Treatment Market Size (2018-2029) & (US$ Million)
Figure 41. France Neuroblastoma Treatment Market Size (2018-2029) & (US$ Million)
Figure 42. U.K. Neuroblastoma Treatment Market Size (2018-2029) & (US$ Million)
Figure 43. Italy Neuroblastoma Treatment Market Size (2018-2029) & (US$ Million)
Figure 44. Russia Neuroblastoma Treatment Market Size (2018-2029) & (US$ Million)
Figure 45. Nordic Countries Neuroblastoma Treatment Market Size (2018-2029) & (US$ Million)
Figure 46. Asia-Pacific Neuroblastoma Treatment Market Share by Region (2018-2029)
Figure 47. China Neuroblastoma Treatment Market Size (2018-2029) & (US$ Million)
Figure 48. Japan Neuroblastoma Treatment Market Size (2018-2029) & (US$ Million)
Figure 49. South Korea Neuroblastoma Treatment Market Size (2018-2029) & (US$ Million)
Figure 50. Southeast Asia Neuroblastoma Treatment Market Size (2018-2029) & (US$ Million)
Figure 51. India Neuroblastoma Treatment Market Size (2018-2029) & (US$ Million)
Figure 52. Australia Neuroblastoma Treatment Market Size (2018-2029) & (US$ Million)
Figure 53. Latin America Neuroblastoma Treatment Market Share by Country (2018-2029)
Figure 54. Mexico Neuroblastoma Treatment Market Size (2018-2029) & (US$ Million)
Figure 55. Brazil Neuroblastoma Treatment Market Size (2018-2029) & (US$ Million)
Figure 56. Middle East & Africa Neuroblastoma Treatment Market Share by Country (2018-2029)
Figure 57. Turkey Neuroblastoma Treatment Market Size (2018-2029) & (US$ Million)
Figure 58. Saudi Arabia Neuroblastoma Treatment Market Size (2018-2029) & (US$ Million)
Figure 59. UAE Neuroblastoma Treatment Market Size (2018-2029) & (US$ Million)
Figure 60. Bottom-up and Top-down Approaches for This Report